| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
It has been shown that bacterial exoproducts may induce airway epithelium injury. During the epithelial repair process,
the respiratory epithelial cells no more establish tight junctional intercellular complexes and may be particularly susceptible to bacterial virulence factors. In this study, we analyzed
the effect of Pseudomonas aeruginosa exotoxin A (ETA) at different periods of time and concentrations on 16 HBE 14o
human bronchial epithelial cells in culture conditions inducing a
phenotype of repairing cells. ETA treatment for 24 and 48 h led to the killing of 40.0 ± 5.7% and 79.0 ± 1.4% of the cells, respectively, as determined by the dimethylthiazole 2,5 diphenyl tetrazolium bromide assay. At 1,000 ng/ml, ETA led to the
killing of 25.2 ± 6.6, 59.4 ± 5.9, and 82.3 ± 3.7% of the cells,
after treatment periods of 7, 24, and 48 h, respectively. Cell
death could not be inhibited by z-VAD-fmk, a broad spectrum
caspase inhibitor. By transmission electron microscopy, ultrastructural characteristics described in apoptosis were not detected in ETA-treated cells. Instead, the mitochondria of cells
treated for 24 and 48 h with ETA at 100 and 1,000 ng/ml were
highly condensed. Human nasal polyp epithelial cells in primary culture exposed to ETA at 1,000 ng/ml did not exhibit
characteristic features of apoptotic cells either. Cytofluorometric analysis of ETA-treated 16 HBE 14o
cells labeled with
DiOC6(3) and hydroethidine showed a time- and dose-dependent reduction of the mitochondrial transmembrane potential,
detected 7 h after ETA treatment, and an increase in superoxide production, detected at 24 h, respectively. By a photometric assay, DNA degradation was also detected 7 h after cell
treatment with ETA at 100 and 1,000 ng/ml. Taken together,
our results show that ETA-induced death of epithelial respiratory cells was preceded by early mitochondrial dysfunction
and superoxide anion production, but was not followed by
the classically described apoptotic pathways.
| |
Introduction |
|---|
|
|
|---|
Pseudomonas aeruginosa is a major respiratory pathogen of immunocompromised individuals and patients with cystic fibrosis (CF). Both inflammatory mediators and bacterial virulence factors likely contribute to injury of infected airway epithelia, to the shedding of surface epithelial cells, and to the persistence of P. aeruginosa infection (1).
The virulence of P. aeruginosa is multifactorial and includes a wide variety of cell-associated and extracellular proteins. Exotoxin A (ETA), reported to be the most toxic exoproduct of P. aeruginosa, is synthesized by most bacterial clinical strains (2) under the regulatory control of the lasR-lasI quorum-sensing system (3). The toxin enters into host cells via receptor-mediated endocytosis, is cleaved in the endocytic vesicles, and translocated into the cytoplasm, where it catalyzes the transfer of the ADP-ribosyl moiety of NAD+ to elongation factor 2 (EF-2). Inactivation of EF-2 leads to inhibition of protein synthesis and to host cell death (4).
In vivo studies have reported that ETA presents considerable target specificity, the inhibition of protein synthesis being greatest and earliest in the liver of inoculated mice (5). Moreover, in vitro studies have shown that cultured cell lines exhibit differential levels of sensitivity to the toxin also (6, 7). Because receptor-mediated endocytosis is a prerequisite for ETA action, variation in cell susceptibility likely depends on the availability of appropriate receptors for the toxin on cell surfaces.
ETA has been detected in respiratory secretions from patients with CF (8), but the role of the toxin in the induction of airway epithelial injury has not yet been clearly established. Indeed, treatment of hamster tracheal explant with high concentrations of purified toxin caused only a mild disorganization of the epithelium (9), whereas studies performed with type II pneumocytes and with different epithelial cell types showed that receptors for this toxin were limited to basolateral domains of cell membranes (10, 11).
In intact epithelia, junctional complexes between adjacent cells provide high-resistance intercellular seals. Intercellular tight junctions also separate apical and basolateral domains of cell membranes, assisting in the maintenance of epithelial cell polarity (12). During the repair of epithelial wounds, intercellular junctions are disrupted not only in the wounded area but also between uninjured cells at some distance from the area of trauma (13, 14), and apical membranes of airway cells exhibit molecules usually restricted to basolateral membranes (15).
Several pathogens, including some bacteria, viruses, and parasites, are able to trigger apoptosis of mammalian cells (16). Depending on the pathogen, apoptosis may be detrimental (17) or beneficial (18) to the survival of host organisms. Although P. aeruginosa infection can induce the apoptotic death of different mammalian cell types (19), both in vivo (22) and in vitro (23) studies have shown that the normal airway epithelium is highly resistant to P. aeruginosa-induced apoptosis. In contrast, cells that do not form intercellular tight junctions, or polarized cells from confluent monolayers treated with Ca2+ chelators to disrupt tight junctions, were shown to be susceptible to apoptosis induced by P. aeruginosa infection (23). The ability of P. aeruginosa to trigger apoptosis in airway cells was shown to depend also on bacterial virulence factors (23).
P. aeruginosa ETA has been reported to induce apoptosis of different mammalian cell types (24), but the effects of the toxin on the induction of apoptosis in airway cells have not been investigated so far.
In this report, we investigated the effect of purified
ETA on the induction of apoptosis of epithelial airway cells
of the 16 14o
HBE line in culture conditions inducing a
phenotype of nonpolarized repairing airway epithelial cells
(14, 27). Cells were shown to be highly susceptible to the
toxin in the range of the concentrations detected in respiratory secretions from P. aeruginosa-infected patients (8).
However, ETA induced a range of biochemical and morphologic changes in airway cells which are not characteristic of apoptosis. Human airway epithelial cells dissociated
from nasal polyps grown in primary culture and exposed
to ETA did not exhibit characteristic features of apoptotic
cells either.
| |
Materials and Methods |
|---|
|
|
|---|
Reagents
Purified ETA was obtained from Swiss Serum and Vaccine Institute (Berne, Switzerland). All other reagents used were from Sigma Chemical Co (St. Louis, MO), unless otherwise indicated.
Airway Epithelial Cell Culture
A 16 HBE 14o
human bronchial epithelial cell line (28), kindly
provided by Dr. Gruenert (University of California at San Francisco, San Francisco, CA), was grown in 199 M culture medium containing 10% fetal calf serum, glutamine, and antibiotics (complete culture medium) on uncoated 24- or 96-well culture dishes.
To assess cell culture tightness, confluent monolayers were submitted to immunolabeling of ZO-1 protein by fluorescence microscopy and to ultrastructural localization of lanthanum nitrate in
intercellular spaces by transmission electron microscopy, as described previously (27). Confluent cultures were treated with ETA
at 10 and 100 ng/ml, a range of concentrations detected in respiratory secretions from P. aeruginosa infected patients (8), and also
at 1,000 ng/ml for different periods of time. Control cells were incubated with complete culture medium only.
In a few assays, primary cultures of human nasal polyp epithelial cells (HNPC), obtained and cultured on microplate wells coated with thin collagen I films as previously described (15), were exposed to ETA at 1,000 ng/ml for different periods.
Viability of ETA-Treated Cells
Two complementary approaches were used to investigate the cytotoxic effect of ETA: (i) the dimethylthiazole 2,5 diphenyl tetrazolium bromide (MTT) viability assay (29), and (ii) the cytofluorometric analysis of cell membrane permeability to propidium iodide which enters only into dead cells (30). In the MTT assay, ETA-treated and untreated cells were incubated with MTT at 1 mg/ml in culture medium for 1 h. Supernatants were then removed and cells were treated with isopropanol, to dissolve the formazan crystals formed in viable metabolically active cells. The A570 nm of supernatants from ETA-treated and -untreated cells was determined with an automatic microplate scanning spectrophotometer (BioRad Laboratories, Richmond, CA). The percentage of viability of toxin-treated cultures was calculated by the formula (A570 nm of ETA-treated culture/A570 nm of untreated control culture) × 100. In the analysis of cell permeability to propidium iodide by flow cytometry, ETA-treated and control untreated cells were detached from the microplate wells with a 0.05% trypsin-0.02% ethylenediaminetetraacetic acid solution and pooled with spontaneously detached cells present in cell culture supernatants. After rinsing, cells were resuspended in phosphate-buffered saline (PBS) pH 7.2 containing 1% bovine serum albumin (PBS-BSA) and incubated with propidium iodide at 5 µg/ml final concentration for 5 min at room temperature (19). Samples were transported on ice and analyzed with a FACScalibur flow cytometer (Becton Dickinson, San Jose, CA) equipped with a standard argon-ion laser. The rational for this approach is that nonviable necrotic and late apoptotic cells lose their membrane integrity and are therefore permeable to the fluorescent DNA-intercalating dye (31). At least 10,000 cells were analyzed in each assay. The results were expressed as the percentage of the fluorescence medians of ETA-treated cells, taking the median of fluorescence of untreated cells as 100%.
Mitochondrial Transmembrane Potential and Superoxide Anion Production
Control untreated and ETA-treated cells were trypsinized from the microplate wells and pooled with spontaneously detached cells present in cell culture supernatants. After rinsing, cells were resuspended in PBS-BSA and incubated for 15 min at 37°C with 40 nM 3, 3' dihexyloxacarbocyanine iodide (DiOC6[3]; Molecular Probes, Eugene, OR) and with 2 µM dihydroethidine (HE). Samples were transported on ice and analyzed within 1 h with a FACScalibur flow cytometer. Assays were repeated three times and in each case at least 10,000 cells were analyzed. DiOC6(3) is a lipophilic cationic fluorochrome that accumulates in the mitochondrial matrix proportionally to their transmembrane potential (32), whereas HE is a nonfluorescent reduced probe that enters into eucaryotic cells and is converted to the fluorescent DNA- intercalating ethidium molecule through superoxide anion oxidation (33).
In a few assays, 16HBE 14o
cells were incubated with ETA
at 1,000 ng/ml for 24 h. Thereafter, cells were stained for 2 h with DiOC6(3) and for 30 min with Hoechst 33258 (100 µg/ml), and
the culture dishes were placed on the stage of an inverted microscope (Nikon TE300; Nikon, Tokyo, Japan) equipped with a cooled
CCD camera (Micromax; Roper Scientific, Tucson, Arizona) connected to a PC computer (DELL Optiplex GX1; Dell, Austin, TX)
and driven by the Metafluor software (Universal Imaging Corporation, West Chester, PA). Fluorescent images of cells stained by
DiOC6(3) and Hoechst 33258 were successively recorded at
488 nm excitation/520 nm emission and 360 nm excitation/420 nm
emission, respectively. Five different areas were recorded in untreated and in ETA-treated culture dishes at a ×40 magnification.
The fluorescence intensity corresponding to the DiOC6(3) staining was measured in each image. As positive control, 16HBE
14o
cells were exposed for 15 s to UV radiation and fluorescent
images of the mitochondrial membrane potential and nuclear
DNA staining were recorded 24 h after the UV exposition, as described above. In other few assays, HNPC in primary culture were
incubated simultaneously with DiOC6(3), Hoechst 33258 and
ETA at 1,000 ng/ml and cell fluorescent images were successively
recorded for up 72 h.
Transmission Electron Microscopy
ETA-treated and -untreated cells were fixed for 1 h at 4°C in a
solution containing 2% glutaraldehyde, 4% paraformaldehyde, and 5 mM CaCl2 in 0.1M cacodylate buffer pH 7.2. After washing, cells were post-fixed for 1 h at room temperature with a solution containing 1% OsO4, 5 mM CaCl2, and 0.8% potassium ferrocyanide in cacodylate buffer, dehydrated through graded ethanol
series and embedded in Epon. Ultrathin sections were observed
with a 906 Zeiss transmission electron microscope. In morphometric studies, an image analyzer (SIS-Auto Image Processing
System, Münster, Germany) connected to the microscope was used
to draw the outlines of mitochondria from untreated and ETA-treated cells. The areas of an equal number of mitochondrial longitudinal and transverse sections were determined in untreated
and in toxin-treated cells. A mitochondrial section was arbitrarily
considered to be longitudinal when the relationship between the
major axis versus the minor axis was
1.5, and transverse when
this relationship was < 1.5.
DNA Fragmentation Analysis
Two different assays were used to detect and characterize DNA fragmentation : (i) conventional agarose gel electrophoresis was performed according to a method described by Herrmann and coworkers (34); (ii) photometric determination of histone-associated DNA fragments was performed with the sensitive Cell Death Detection Enzyme-Linked Immunosorbent Assay (Roche Diagnostic Corp., Mannheim, Germany), according to the manufacturer's instructions.
Effect of Caspase Inhibitor on Airway Cell Death
Cells cultured on uncoated microplate wells were treated with 100 µM of the cell-permeable tripeptide z-Val-Ala-Asp-fluoromethylketone (zVAD-fmk; Bachem Biochimie, Voisins-le-Bretonneux, SARL), a broad spectrum inhibitor of most mammalian caspases (35), for 1 h before incubation with different concentrations of ETA in culture medium. In parallel, untreated cells were exposed to the same concentrations of the toxin. After a 24-h incubation period, the viability of zVAD-fmk-treated and -untreated cells was assessed by the MTT assay.
Statistical Analyses
Results are expressed as means ± SEM of data obtained in experiments performed at least in triplicate. Statistical differences were determined using the Student's t test. A P value below 0.05 was considered statistically significant.
| |
Results |
|---|
|
|
|---|
Characterization of 16 HBE 14o
Cells Used to Assess the
Effects of P. aeruginosa ETA
Confluent monolayers cultured on uncoated supports did not establish intercellular tight junctional complexes because they were permeable to lanthanum nitrate, which was detected delineating adjacent cells (Figure 1). Moreover, only a few cells exhibited a positive pericellular labeling with a monoclonal antibody against ZO-1, a protein characteristic of tight junctional complexes (data not shown).
|
Effect of ETA on 16 14o
HBE Epithelial Airway
Cell Viability
In preliminary assays, the cells were exposed to the toxin for short periods (30, 60, and 120 min), rinsed, and incubated in complete culture medium for up to 24 h. Thereafter, viability of control and ETA-treated cells was determined by the MTT assay. Figure 2A shows that the viability of cells treated with ETA at 100 ng/ml was only slightly decreased (85.4 ± 5.0 and 78.0 ± 8.4% of control cells) after incubation period of 60 and 120 min, respectively. At 1,000 ng/ml, ETA was significantly (P < 0.01) more cytotoxic after an incubation period as short as 30 min. In other assays, cells were exposed continuously to ETA for longer periods. Cell treatment for 7 h with ETA at 10 or 100 ng/ml did not affect the viability of untight airway cells. However, when the treatment period was extended to 24 and 48 h, or when the ETA concentration was augmented to 1,000 ng/ml, cell viability decreased proportionally to the toxin concentration and incubation period, reaching only 18.2 ± 3.7% in cultures exposed to 1,000 ng/ml of the toxin for 48 h (Figure 2B; Table 1). Insofar as the MTT assay does not allow one to distinguish apoptotic from necrotic cells, toxin-treated cells were exposed to propidium iodide that enters only in cells with permeable membranes, as observed in primary necrosis and in late apoptosis (secondary necrosis), but not in early apoptosis (31). As shown in Figure 2C, cells treated with ETA at different concentrations for 7 h, and with ETA at 10 ng/ml for 24 and 48 h, did not incorporate significantly the dye, as shown by their propidium iodide labeling which was similar to or lower than the labeling of control cells. In contrast, cells treated with ETA at 100 and 1,000 ng/ml for 24 and 48 h incorporated significantly more propidium iodide than controls (Figure 2C), suggesting the occurrence of secondary necrosis. Because a few cells treated with ETA at 10 ng/ml for 24 and 48 h, and with the toxin at 1,000 ng/ml for 7 h, were shown to be dead by the MTT assay (Figure 2B), and did not incorporate the propidium iodide, we hypothesized that a few cells conserved a selective permeability of their membranes and that in these cells, death was possibly related to an apoptotic mechanism.
|
Mitochondrial Transmembrane Potential (
m) and
Superoxide Anion Generation
Mitochondrial dysfuntion has been shown to be an early
and irreversible event of apoptosis (32). To further investigate the effects of ETA on epithelial respiratory cells, control untreated and ETA-treated cells were incubated with
the 
m-sensitive fluorochrome DiOC6(3) and with HE,
which is oxidized to ethidium by superoxide anion generation. The median values of the labeling intensity of ETA-treated cells were compared with median values of control untreated cells, referred to as 100%. As shown in Figure 3
and Table 1, ETA induced a progressive loss in mitochondrial transmembrane potential and a concomitant increase
in the generation of superoxide anion. The first phenomenon frequenty occurs in early steps of apoptosis (32), whereas
the second has been detected only in certain apoptotic processes (36).
|
In a few assays, 16 HBE 14o
cells cultured on glass
coverslips were treated with ETA at 1,000 ng/ml for 24 h,
and then exposed to DiOC6(3) and Hoechst 33258 to assess chromatin condensation. Cell observation with an inverted microscope equipped with a CCD camera showed
no significant difference in mitochondrial transmembrane potential between ETA-treated and -untreated cells (mean
green fluorescence intensity of 40.5 ± 5.8 and 35.5 ± 8.5, respectively; Figures 4C and 4D). Hoechst staining did not
reveal any significant difference in nuclear morphology
between ETA-treated and -untreated cells. In contrast,
cells exposed to UV irradiation, a known inducer of cell
apoptosis (37), exhibited typical apoptotic nuclear morphology, characterized by condensed and fragmented chromatin (Figure 4F).
|
It has been reported that cell lines may be prevented
from exhibiting characteristic apoptotic morphology (38).
To address the question whether the absence of chromatin
condensation and/or fragmentation in ETA-treated 16 HBE14o
cells depended on the cell immortalization process, airway cells in primary culture were treated simultaneously with the toxin at 1,000 ng/ml, with DiOC6(3) and
Hoechst 33258 and observed continuously under an inverted microscope. No significant difference in mitochondrial fluorescence or nuclear morphology was detected in
HNPC exposed to ETA for as long as 48 h. In contrast, between 48 and 72 h, many cells were seen to round up and
to detach from the microplate wells (data not shown).
Transmission Electron Microscopy
To further investigate the mechanism of airway cell death by ETA, ultrastructural characterisitics of apoptosis were investigated by transmission electron microscopy. A few 16 HBE cells treated with ETA at 100 ng/ml for 24 h exhibited perinuclear condensed chromatin typical of an apoptotic process, but they also presented disrupted cytoplasmic plasma membranes, suggestive of secondary necrosis (Figure 5A). These ultrastructural characteristics were not observed in untreated cells (data not shown). Other ultrastructural features of apoptosis, such as nuclear and plasma membrane blebbing, presence of cells with fragmentated and/or condensed nuclei, and presence of apoptotic bodies, were never observed in cells under ETA treatment. It is worthy of note that in many ETA-treated cells presenting unchanged nucleus, some mitochondria were found to be highly deformed and condensed (Figures 5C and 5D), compared with mitochondria from untreated cells (Figure 5B). Mitochondrial condensation was confirmed by morphometric studies: the areas of organelles from cells treated with ETA at 100 ng/ml for 24 or 48 h (0.3 ± 0.02 and 0.2 ± 0.02 µm2, respectively) were significantly lower (P < 0.01) than the areas of organelles from control cells (0.8 ± 0.05 µm2). No significant difference was detected between areas of mitochondria from controls and from cells treated with ETA at 100 ng/ml for 7 h (0.7 ± 0.06 µm2).
|
Analysis of DNA Fragmentation Pattern
The biochemical hallmark of apoptosis is the cleavage of
chromatin into internucleosomal fragments, resulting in
multimers of 180 to 200 bp (31, 38). However, instead of
typical laddering pattern, large DNA fragments were observed after agarose gel electrophoresis of DNA extracted
from 16 HBE or HNPC cells treated with ETA at 100 and
1,000 ng/ml for 24 h (data not shown). In contrast, the pattern of histone-associated DNA fragments detected by the
enzyme-linked immunosorbent assay in ETA-treated 16 HBE 14o
cell supernatants and lysates evokes a mode of
DNA fragmentation corresponding to apoptosis (Figures
6A and 6B). In necrosis, cells lose plasma membrane integrity at an early phase of cell death. In contrast, during
apoptosis, the integrity of plasma membranes is maintained until the onset of secondary necrosis. Accordingly, in apoptosis, DNA fragments are likely to be detected only
in cell lysates, whereas in necrosis, they can be detected
both in cell lysates and supernatants. In our study, DNA
fragments were detected in cell lysates 7 h after ETA treatment and their concentration increased proportionally
with the toxin concentrations and incubation periods (Figure 6A and Table 1). In cell cultures treated for 24 or 48 h
with ETA whatever the concentration, higher concentrations of DNA fragments were detected in cell supernatants than in control cell supernatants (Figure 6B), suggesting either the occurrence of an apoptotic process
followed by secondary necrosis or a process similar to necrosis. Therefore, the analysis of the mode of DNA fragmentation occurring in the presence of ETA revealed a
complex process evoking apoptosis at early times of treatment and necrosis at late times of treatment.
|
Effect of Caspase Inhibitor on ETA-Induced Airway Cell Death
Different studies have shown the role of caspases in ETA-induced eukaryotic cell apoptosis (25, 26). Therefore, to
further investigate the mechanism of airway cell death,
zVAD-fmk, a broad spectrum caspase inhibitor, was added
to 16 HBE 14o
cells 1 h before a 24-h incubation period
with ETA. As shown in Figure 7, zVAD-fmk had no significant effect on ETA-induced airway cell death, as assessed by the MTT assay.
|
| |
Discussion |
|---|
|
|
|---|
Infections of the respiratory tract by P. aeruginosa are very frequent in CF and in immunocompromised patients. High proteolytic activity in sputa of these patients, mainly derived from polymorphonuclear leukocytes, has been shown to account for severe pulmonary damage (39). It is less clear, however, whether specific P. aeruginosa extracellular enzymes may contribute to airway damage in these patients.
ETA is a potent inhibitor of protein synthesis produced
by most of the clinical isolates of P. aeruginosa. Jaffar and
colleagues (8) have shown a positive correlation between
the level of this toxin in bronchial secretions and the exacerbation periods in CF. However, insofar as ETA has been
reported to bind to
2-macroglobulin receptors (40), located exclusively on basolateral membranes of polarized
cells, the mechanism used by this toxin to contribute to epithelial damage in P. aeruginosa-infected patients remained to be determined. The main finding of this report is that
ETA induces the death of airway epithelial cells, which are
reminiscent of repairing epithelial cells found in remodeling airway epithelium, that do no exhibit intercellular tight
junctional complexes (14). Interestingly, it has been recently reported by Rajan and coworkers (23) that the susceptibility of epithelial respiratory cells to P. aeruginosa-
induced apoptosis is at least partially dependent on the integrity of tight junctional complexes. Our results not only
confirm the susceptibility of airway cells that do not establish tight intercellular junctional complexes to the cytotoxic effect of bacterial exoproducts; they also demonstrate
that ETA is a P. aeruginosa virulence factor that may be
directly involved in airway cell death.
Studies performed in the early 1990s (24, 41) reported
that ETA, as well as other inhibitors of protein synthesis,
induced apoptosis of mammalian cells characterized by
chromosomal DNA degradation into oligonucleosome-sized
fragments, chromatin condensation, and cell nuclei fragmentation. Further studies have confirmed the capability
of ETA to induce cell death by apoptosis (25, 26, 42).
However, in our experimental conditions, 16 HBE 14o
cells did not exhibit any morphologic changes described in
apoptotic cells, as assessed by fluorescence videomicroscopy and by transmission electron microscopy.
In previous studies, it has been reported that cells may
undergo apoptosis although lacking some nuclei and cellular morphologic features of apoptotic cells (43, 44), and
that cell lines may be prevented from exhibiting apoptotic
characteristics through the loss of signal transduction pathways or metabolic components during the immortalization
process (38). To ascertain whether the lack of apoptotic
characteristics in ETA-treated 16 HBE 14o
cells resulted
from the immortalization process, we analyzed the morphologic changes in cells exposed to ionizing radiation, a
known inducer of apoptosis (37). In contrast to cells exposed to ETA, UV-treated cells exhibited characteristic
nuclei shrinkage and chromatin condensation, easily visualized after nucleous staining with the DNA-binding Hoechst
fluorophore. Because different cell types may differ in their
susceptibility to apoptotic stimuli, we then investigated the
effects of ETA on airway cells in primary culture. For this
study, HNPC were grown on a thin film of collagen I, to
prevent the establishment of tight junctional complexes (27). After treatment with ETA at 1,000 ng/ml, and with
the fluorophores DiOC6(3) and Hoechst, images of the
cells were recorded for a 72-h period. Unexpectedly, HNPC
did not show nuclear changes or mitochondrial depolarization reported in apoptotic cells, but within 48-72 h they
were seen to detach from the microplate wells and to die.
Altogether, these results raised doubts about the capability of ETA to induce apoptosis of 16 HBE cells. We therefore investigated additional criteria currently used to define the mechanism of cell death, based on mitochondrial
activity, DNA fragmentation pattern, and effect of caspase
inhibitor on cell viability.
Mitochondrial changes are known to play key roles in
various apoptotic processes (45). In particular, the loss of
mitochondrial transmembrane potential has been proposed as a constant, early, and irreversible event of apoptosis (46, 47). However, mitochondrial depolarization has
also been described in autophagy and in necrosis (48). In
our study, flow cytometric analysis of ETA-treated 16 HBE 14o
labeled with DiOC6(3) showed a time- and dose-dependent depolarization of the mitochondrial membranes.
In contrast, when investigated by video microscopy, no
significant difference in mitochondrial transmembrane potential was detected between ETA-treated and -untreated cells. The differences between the results obtained with
these two approaches may stem from the kind of cells under study. In the FACS assays, both airway cells that had
detached spontaneously from the monolayer cultures under the effect of the toxin, and cells detached from the microplate wells by trypsinization, were analyzed. In contrast, in the videomicroscopy assays, only cells remaining
adherent to the glass coverslips, which correpond to cells
that had to be trypsinized from the microplates in the FACS assay, were analyzed.
In response to mitochondrial dysfuntion, large transmembrane pores are likely to open, a phenomenon known as the mitochondrial permeability transition (MPT). Activation of MPT is associated with the translocation from the mitochondria into the cytosol of numerous mitochondrial proteins such as cytochrome c (49), apoptosis-inducing factor (AIF) (50), and Smac/DIABLO (51). Activation of MPT also allows ions to emerge from mitochondria, and the intake of water into the mitochondrial matrix, resulting in osmotic swelling and rupture of the cristae and of the organelle outer membrane (47, 52). In our study, as well as in others (53, 54), the presence of mitochondrial condensation and the lack of mitochondrial swelling suggest that the activation of MPT played a minor role in ETA-induced cell killing. Interestingly, condensed mitochondria have been described by Laiho and coworkers (55) and by Papapdimitriou and colleagues (56) as a short-term response to cell injury. In these latter studies, however, condensation was followed by a rapid return to the normal configuration, followed by the development of morphologic changes that are normally associated with necrosis. Unlike this transient response to injury, the changes observed in our study were present in cells treated with ETA for as long as 48 h.
In addition to morphologic changes of mitochondria and to the loss of mitochondrial transmembrane potential, we also observed an increase in superoxide anions in ETA-treated cells. As oxygen intermediate anions react with macromolecules, either damaging them directly or setting in motion a chain reaction wherein the free radical is passed from one macromolecule to another, superoxide anion production may induce modifications at various cellular levels. In the present work, the enhanced production of superoxide anions may have produced cell membrane damage revealed by increased permeability to propidium iodide as well as by the irregular degradation of DNA (57).
DNA degradation into oligonucleosome-sized fragments resulting from the activation of endonucleases has been considered the biochemical hallmark of apoptosis. This produces a characteristic laddering pattern of cleavage when DNA from apoptotic cells is subjected to conventional agarose gel electrophoresis. In our study, no typical ladder pattern of fragmentation was detected by agarose gel electrophoresis of DNA extracted from ETA-treated 16 HBE or HNPC cells in primary culture. Cleavage of DNA to 50-kbp fragments, preceeding the appearance of 180- to 200-bp oligonucleosomal fragments, has been detected in several models of epithelial and mesenchymal cell apoptosis (58). In one of these models, although the cells exhibited classic apoptotic morphology, no subsequent internucleosomal cleavage was observed. Because DNA laddering pattern can no longer be considered mandatory in an apoptotic cell death, we next assessed DNA fragmentation in ETA-treated cells by using a photometric determination of histone-associated DNA fragments assay. DNA fragments were detected in the cytoplasm of ETA-treated cells that preserved the integrity of their plasma membranes, a feature described in apoptotic cells.
Finally, in our attempt to define the capability of ETA to induce apoptosis of airway cells, we analyzed the effects of cell treatment with the permeable caspase inhibitor z-VAD-fmk on 16 HBE cell viability. Due to an aspartate residue mimicking the cleavage site and a fmk group forming a covalent inhibitor/enzyme complex, the inhibitor instantly and irreversibly binds to the catalytic site of caspases. In our study, no significant difference was observed between z-VAD-fmk- treated and -untreated cell viability. This result contrasts with those obtained in other studies on the effect of P. aeruginosa ETA on mammalian cells, in which cell apoptosis could be significantly inhibited by the caspase inhibitor (25, 26). Taken together, our observations suggest that ETA induces the death of airway cells that mimic repairing cells found in wounded epithelia by a yet unknown mechanism different from the classically described apoptosis mechanism. We speculate that in infected patients ETA-induced death of airway cells may represent an additional mechanism of epithelial injury favoring the persistence of bacterial infection.
|
| |
Footnotes |
|---|
Address correspondence to: Maria-Cristina Plotkowski, Department of Microbiology and Immunology, FCM/ UERJ, Av. 28 de Setembro, 87 fundos, 3° andar. 20 551-030, Rio de Janeiro, Brazil. E-mail: mcplot{at}uerj.br
Abbreviations: cystic fibrosis, CF; elongation factor 2, EF-2; exotoxin A, ETA; dihydroethidine, HE; human nasal polyp epithelial cells, HNPC; mitochondrial permeability transition, MPT; dimethylthiazole 2,5 diphenyl tetrazolium bromide, MTT.Acknowledgments: The authors thank Dr. Claude Galabert (CERM, Hôpital Renée Sabran, Giens, France) for providing the exotoxin A, Iris M. P. Alvim for her help with flow cytometric analysis, and Marco Antônio de F. Maciel for his help with transmission electron micrographs. This work was supported by grants from Association Vaincre la Mucoviscidose (France), FAPERJ, and from FINEP/MCT/PRONEX (41 960 881.00; Brazil).
| |
References |
|---|
|
|
|---|
1. de Bentzmann, S., M. C. Plotkowski, and E. Puchelle. 1996. Receptors in the Pseudomonas aeruginosa adherence to injured and repairing airway epithelium. Am. J. Respir. Crit. Care Med. 154: S155-S162 .
2. Vasil, M. L., R. W. Prince, and V. D. Shortridge. 1993. Exoproducts: Pseudomonas aeruginosa exotoxin A and phospholipase C. In Pseudomonas aeruginosa, the Opportunist: Pathogenesis and Disease. R. B. Fick, editor. CRC Press, Boca Raton, FL. 59-77.
3.
de Kievit, T. R., and
B. H. Iglewski.
2000.
Bacterial quorum sensing in
pathogenic relationships.
Infect. Immun.
68:
4839-4849
4.
Ogata, M.,
V. K. Chaudhary,
I. Pastan, and
D. J. Fitzgerald.
1990.
Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000 Da toxin fragment that is translocated to the cytosol.
J.
Biol. Chem.
265:
20678-20685
5.
Pavlovskis, O. R., and
A. H. Shackelford.
1974.
Pseudomonas aeruginosa exotoxin in mice: localization and effect on protein synthesis.
Infect. Immun.
9:
540-546
6. Pavlovskis, O. R., and F. B. Gordan. 1972. Pseudomonas aeruginosa exotoxin: effect on cell cultures. J. Infect. Dis. 125: 631-636 [Medline].
7. Middelbrook, J. L., and R. B. Dorland. 1977. Response of cultured mammalian cells to the exotoxins of Pseudomonas aeruginosa and Corynebacterium diphtheriae: differential cytotoxicity. Can. J. Microbiol. 23: 183-189 [Medline].
8. Jaffar-Bandjee, M. C., A. Lazdunski, M. Bally, J. Carrère, J. P. Chazalette, and C. Galabert. 1995. Production of elastase, exotoxin A, and alkaline protease in sputa during pulomonary exarcebation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. J. Clin. Microbiol. 33: 924-929 [Abstract].
9. Baker, N. R.. 1981. Role of exotoxin A and proteases of Pseudomonas aeruginosa in respiratory tract infections. Can. J. Microbiol. 28: 248-255 .
10.
Melby, E. L.,
J. Jacobsen,
S. Olsnes, and
K. Sandvig.
1993.
Entry of protein
toxins in polarized epithelial cells.
Cancer Res.
53:
1755-1760
11. Azghani, A. O.. 1996. Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A. Am. J. Respir. Cell Mol. Biol. 15: 132-140 [Abstract].
12. Molitoris, B. A., and W. J. Nelson. 1990. Alterations in the establishment and maintenance of epithelial cell polarity as a basis for disease processes. J. Clin. Invest. 85: 3-9 .
13. Gordon, R. E., and B. P. Lane. 1976. Regeneration of rat tracheal epithelium after mechanical injury: restoration of surface integrity during the early hours after injury. Am. Rev. Respir. Dis. 113: 799-807 [Medline].
14. Herard, A. L., J. M. Zahm, D. Pierrot, J. Hinnrasky, C. Fuchey, and E. Puchelle. 1996. Epithelial barrier integrity during in vitro wound repair of the airway epithelium. Am. J. Respir. Cell Mol. Biol. 15: 624-632 [Abstract].
15.
Herard, A.L., D. Pierrot, J. Hinnrasky, H. Kaplan, D. Sheppard, E. Puchelle, and J. M. Zahm. 1996. Fibronectin and
5
1 receptors are involved in the wound repair process of the airway epithelium. Am. J. Physiol. (Lung Cell Mol. Physiol.) 271:L726-L733.
16. Zylchinsky, A., and P. Sansonetti. 1997. Apoptosis and bacterial pathogenesis. J. Clin. Invest. 100: 493-495 [Medline].
17.
Kitamura, Y.,
S. Hashimoto,
N. Mizuta,
A. Kobayashi,
K. Kooguchi,
J. Fujiwara, and
H. Nakajima.
2001.
Fas/FasL-dependent apoptosis of alveolar
cells after lipopolysaccharide-induced lung injury in mice.
Am. J. Respir.
Crit. Care Med.
163:
762-769
18.
Grassmé, H.,
S. Kirschnek,
J. Riethmueller,
A. Riehle,
G. von Kürthy,
F. Lang,
M. Weller, and
E. Gulbins.
2000.
CD95/CD95 ligand interactions on epithelial
cells in host defense to Pseudomonas aeruginosa.
Science
290:
527-530
19.
Hauser, A. R., and
J. N. Engel.
1999.
Pseudomonas aeruginosa induces
type-III-secretion-mediated apoptosis of macrophages and epithelial cells.
Infect. Immun.
67:
5530-5537
20. Valente, E., M. C. Assis, I. M. P. Alvim, G. M. B. Pereira, and M. C. Plotkowski. 2000. Pseudomonas aeruginosa induces apoptosis in human endothelial cells. Microb. Pathog. 29: 345-356 [Medline].
21.
Jendrossek, V.,
H. Grassmé,
I. Mueller,
F. Lang, and
E. Gulbins.
2001.
Pseudomonas aeruginosa-induced apoptosis involves mitochondria and
stress-activated protein kinases.
Infect. Immun
69:
2675-2683
22. Hotchkiss, R., W. M. Dunne, P. E. Swanson, C. G. Davis, K. W. Tinsley, K. C. Chang, T. G. Buchman, and I. E. Karl. 2001. Role of apoptosis in Pseudomonas aeruginosa pneumonia. Science 294: 1783-1791 .
23.
Rajan, S.,
G. Cacalano,
R. Bryan,
A. J. Ratner,
C. H. Sontich,
A. van Heerckeren,
P. Davis, and
A. Prince.
2000.
Pseudomonas aeruginosa induction of
apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial
virulence factors.
Am. J. Respir. Cell Mol. Biol.
23:
304-312
24.
Morimoto, H.,
B. Bona, and
Vida.
1992.
Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2
is required for DNA fragmentation and cell lysis and synergy with tumor
necrosis factor
.
J. Immunol.
149:
2089-2094
[Abstract].
25. Keppler-Hafkemeyer, A., U. Brinkmann, and I. Pastan. 1998. Role of caspase in immunotoxin-induced apoptosis of cancer cells. Biochemistry 37: 16934-16942 [Medline].
26.
Komatsu, N.,
T. Oda, and
T. Muramatsu.
1998.
Involvement of both caspase-like proteases and serine proteases in apoptotic cell death induced by
ricin, modeccin, diphtheria toxin, and Pseudomonas toxin.
J. Biochem
124:
1038-1044
27.
Plotkowski, M. C.,
S. de Bentzmann,
S. H. M. Pereira,
J. M. Zahm,
O. Bajolet-Laudinat,
P. Roger, and
E. Puchelle.
1999.
Pseudomonas aeruginosa internalization by human epithelial respiratory cells depends on cell differentiation, polarity and junctional complex integrity.
Am. J. Respir. Cell Mol.
Biol.
20:
880-890
28. Cozzens, A. L., M. J. Yezzi, M. Yamada, D. Steiger, J. A. Wagner, S. S. Garber, L. Chin, E. M. Simon, G. R. Cutting, P. Gardner, D. S. Friend, C. B. Basbaum, and D. C. Gruenert. 1992. Transformed human epithelial cell line that retains tight junctions post crisis. In Vitro Cell Dev. Biol. (Anim.) 28A:735-744.
29. Denizot, F., and R. Lange. 1986. Rapid colorimetric assay for cell growth and survival: modification of the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Meth. 89: 271-277 [Medline].
30. Yeh, C. J., B. L. His, and W. P. Faulk. 1981. Propidium iodide as a nuclear marker in immunofluorescence: II Use with cellular identification and viability studies. J. Immunol. Meth. 43: 269-275 [Medline].
31. Thompson, C. B. 1999. Apoptosis. In Fundamental Immunology. W. E. Paul, editor. Lippincott Raven Publishers, Philadelphia. 813-829.
32.
Zamzami, N.,
P. Marchetti,
M. Castedo,
D. Decaudin,
A. Macho,
T. Hirsch,
S. A. Susin,
P. X. Petit,
B. Mignotte, and
G. Kroemer.
1995.
Sequential reduction of mitochondrial transmembrane potential and generation of rective
oxygen species in early programmed cell death.
J. Exp. Med.
182:
367-377
33. Rothe, G., and G. Valet. 1990. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2, 7-dichlorofluorescein. J. Leukoc. Biol. 47: 440-448 [Abstract].
34.
Herrmann, M.,
H. M. Lorenz,
R. Voll,
M. Grunke,
W. Woith, and
J. R. Kalsen.
1994.
A rapid and simple method for the isolation of apoptotic
DNA fragments.
Nucleic Acids Res.
22:
5506-5507
35.
Garcia-Calvo, M.,
E. P. Peterson,
B. Leiting,
R. Ruel,
D. W. Nicholson, and
N. A. Thomberry.
1998.
Inhibition of human caspases by peptide-based
and macromolecular inhibitors.
J. Biol. Chem.
273:
32608-32613
36. Lizard, G., C. Miguet, G. Bessede, S. Monier, S. Gueldry, D. Neel, and P. Gambert. 2000. Impairement with various antioxidants of the loss of mitochondrial transmembrane potential and of the cytosolic release of cytochrome c occurring during 7-ketocholesterol induced apoptosis. Free Radic. Biol. Med. 28: 743-753 [Medline].
37.
Haimovitz-Friedman, A.,
C. Kann,
D. Ehleiter,
R. S Persaud,
M. McLoughlin,
Z. Fuks, and
R. N. Kolesnik.
1994.
Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis.
J. Exp. Med.
180:
525-535
38. Bortner, C. D., N. B. E. Oldenburg, and J. A. Cidlowski. 1995. The role of DNA fragmentation in apoptosis. Trends Cell Biol. 5: 21-26 . [Medline]
39. Suter, S., U. B. Schaad, L. Roux, U. E. Nydegger, and F. A. Waldvogel. 1984. Granulocyte neutral proteases and Pseudomonas aeruginosa elastase as possible causes of airway damage in patients with cystic fibrosis. J. Infect. Dis. 149: 523-531 [Medline].
40.
Kounnas, M. Z.,
R. E. Morris,
M. R. Thompson,
D. J. FitzGerald,
D. K. Strickland, and
C. B. Saelinger.
1992.
The
2-macroglobulin receptor/low
density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A.
J. Biol. Chem.
267:
1240-1243
.
41. Kochi, S. K., and R. J. Collier. 1993. DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitor of protein synthesis. Exp. Cell Res. 208: 296-302 [Medline].
42. Weisser, M., G. Tiegs, A. Wendel, and S. Uhlig. 1998. Quantification of apoptotic and lytic cell death by video microscopy in combination with artificial neural networks. Cytometry 31: 20-28 [Medline].
43. Camilleri-Broët, S., H. Vanderwerff, E. Caldwell, and D. Hockenbery. 1998. Distinct alterations in mitochondrial mass and function characterize different models of apoptosis. Exp. Cell Res. 239: 277-292 [Medline].
44. Frey, T.. 1997. Correlated flow cytometric analysis of terminal events in apoptosis reveals the absence of some changes in some model systems. Cytometry 28: 253-263 [Medline].
45. Green, D., and G. Kroemer. 1998. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8: 267-271 . [Medline]
46.
Zamzami, N.,
S. A. Susin,
P. Marchetti,
T. Hirsch,
I. Gómez-Monterrey,
M. Castedo, and
G. Kroemer.
1996.
Mitochondrial control of nuclear apoptosis.
J. Exp. Med
183:
1533-1544
47. Petit, P. X., S. A. Susin, N. Zamzami, B. Mignotte, and G. Kroemer. 1996. Mitochondria and programmed cell death: back to the future. FEBS Lett 396: 7-13 [Medline].
48. Lemaster, J. J., A. L. Nieminen, T. Qian, L. Trost, S. P. Elmore, Y. Nishimura, R. A. Crowe, W. E. Cascio, C. A. Bradham, D. A. Brenner, and B. Herman. 1998. The mitochondrial permeability transitionin cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366: 177-196 [Medline].
49. Bossy-Wetzel, E., and D. R. Green. 1999. Caspases induce cytochrome c release from mitochondria by activated cytosolic factors. J. Biol. Chem. 18: 17488-17490 .
50. Susin, A., H. K. Lorenzo, N. Zamzami, I. Marzo, B. E. Snow, G. M. Brothers, J. Mangion, E. Jacotot, P. Costantini, M. Loeffler, N. Goodlett, R. Albersola, D. P. Siderovski, J. M. Penninger, and G. Kroemer. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446 [Medline].
51. Chai, J., C. Du, J. W. Wu, S. Kyin, X. Wang, and Y. Shi. 2000. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406: 855-862 [Medline].
52. Vander Heiden, M. G., N. S. Chandel, E. K. Williamson, P. T. Schumacker, and C. B. Thompson. 1997. Bcl-xl regulates the mebrane potential and volume homeostasis of mitochondria. Cell 235: 421-430 .
53. Jia, L., R. R. Dourmashkin, A. C. Newland, and S. M. Kelsey. 1997. Mitochondrial ultracondensation, but not swelling, is involved in TNF alpha-induced apoptosis in human T-lymphoblastic leukaemic cells. Leuk. Res. 21: 973-983 [Medline].
54.
Dinsdale, D.,
J. Zhuang, and
G. M. Cohen.
1999.
Redistribution of cytochrome
c precedes the caspase-dependent formation of ultracondensed mitochondria, with a reduced inner membrane potential in apoptotic monocytes.
Am. J. Pathol.
155:
607-618
55. Laiho, K. U., and B. F. Trump. 1975. Studies on the pathogenesis of cell injury: effects of inhibitors of metabolism and membrane function on the mitochondria of Ehrlich ascites tumor cells. Lab. Invest. 32: 163-182 [Medline].
56. Papadimitriou, J. C., C. B. Drachenberg, M. L. Shin, and B. F. Trump. 1994. Ultrastructural studies of complement mediated cell death: a biological resaction model to plasma membrane injury. Virchows Arch. 424: 677-685 [Medline].
57. Halliwell, B., and J. M. Gutteridge. 1990. Role of free radical and catalytic metal ions in human disease: an overview. Methods Enzymol. 186: 1-85 [Medline].
58. Oberhammer, F., J. W. Wilson, C. Dive, I. D. Morris, J. A. Hickman, A. E. Wakeling, P. R. Walker, and M. Sikorska. 1993. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12: 3679-3684 [Medline].
This article has been cited by other articles:
![]() |
Y. Tesfaigzi Roles of Apoptosis in Airway Epithelia Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 537 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Travassos, L. A. M. Carneiro, S. E. Girardin, I. G. Boneca, R. Lemos, M. T. Bozza, R. C. P. Domingues, A. J. Coyle, J. Bertin, D. J. Philpott, et al. Nod1 Participates in the Innate Immune Response to Pseudomonas aeruginosa J. Biol. Chem., November 4, 2005; 280(44): 36714 - 36718. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Jenkins, A. Swiatoniowski, A. C. Issekutz, and T.-J. Lin Pseudomonas aeruginosa Exotoxin A Induces Human Mast Cell Apoptosis by a Caspase-8 and -3-dependent Mechanism J. Biol. Chem., August 27, 2004; 279(35): 37201 - 37207. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Coraux, C. Kileztky, M. Polette, J. Hinnrasky, J.-M. Zahm, P. Devillier, S. de Bentzmann, and E. Puchelle Airway Epithelial Integrity Is Protected by a Long-Acting {beta}2-Adrenergic Receptor Agonist Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 605 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Q. O'Malley, M. Y. Abdalla, M. L. McCormick, K. J. Reszka, G. M. Denning, and B. E. Britigan Subcellular localization of Pseudomonas pyocyanin cytotoxicity in human lung epithelial cells Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L420 - L430. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBA |